• Accueil >
  • Publications >
  • De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor

De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor

1 déc. 2019JCO Precision Oncology

DOI : 10.1200/po.18.00398

Auteurs

Adeline Morel, Julien Masliah-Planchon, Guillaume Bataillon, Véronique Becette, Claire Morel, Samantha Antonio, Elodie Girard, Ivan Bièche, Christophe Le Tourneau, Maud Kamal

Membres

ELODIE GIRARD

Ingénieur de recherche